Central and systemic C-type Natriuretic Peptide are both reduced in Parkinson's Disease.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Parkinsonism & Related Disorders

• Publication date

  2017-06-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.parkreldis.2017.06.019PMID 28673612
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• C-type natriuretic peptide and natriuretic peptide receptor B signalling inhibits cardiac sympathetic neurotransmission and autonomic function

  2016cited by this paper
• Biochemical Changes and Cardiovascular Function in Parkinson’s Disease: Precautionary Notes

  2016cited by this paper
• Biomarkers of Parkinson's disease: present and future.

  2015cited by this paper
• Ropinirole treatment in Parkinson's disease associated with higher serum level of inflammatory biomarker NT-proCNP.

  2014cited by this paper
• Bifurcation of Axons from Cranial Sensory Neurons Is Disabled in the Absence of Npr2-Induced cGMP Signaling

  2014cited by this paper
• Dysautonomia in Parkinson disease.

  2014cited by this paper
• C-type natriuretic peptide in Parkinson’s disease: reduced secretion and response to deprenyl

  2014cited by this paper
• Impact of age, phenotype and cardio‐renal function on plasma C‐type and B‐type natriuretic peptide forms in an adult population

  2013cited by this paper
• Cell Surface Expression of the Major Amyloid-β Peptide (Aβ)-degrading Enzyme, Neprilysin, Depends on Phosphorylation by Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase Kinase (MEK) and Dephosphorylation by Protein Phosphatase 1a*

  2012cited by this paper
• Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis.

  2012cited by this paper
• Amino‐terminal propeptide of C‐type natriuretic peptide (NTproCNP) predicts height velocity in healthy children

  2012cited by this paper
• Inflammatory cytokines and NT-proCNP in Parkinson's disease patients.

  2012cited by this paper
• Mapping of NPR-B immunoreactivity in the brainstem of Macaca fascicularis

  2011cited by this paper
• Central and peripheral forms of C-type natriuretic peptide (CNP): evidence for differential regulation in plasma and cerebrospinal fluid.

  2011cited by this paper
• CSF Aβ42 and tau in Parkinson's disease with cognitive impairment

  2010cited by this paper
• Regulation of axonal development by natriuretic peptide hormones

  2009cited by this paper
• Regional Release and Clearance of C-Type Natriuretic Peptides in the Human Circulation and Relation to Cardiac Function

  2009cited by this paper
• Multiplicity of cerebrospinal fluid functions: New challenges in health and disease

  2008cited by this paper
• Cerebrospinal Fluid Research BioMed Central Review Multiplicity of cerebrospinal fluid functions: New challenges in health and disease

  2008cited by this paper
• Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions.

  2006cited by this paper
• Activation of the cGMP Pathway in Dopaminergic Structures Reduces Cocaine-Induced EGR-1 Expression and Locomotor Activity

  2004cited by this paper
• C‐type natriuretic peptide (CNP) regulates cocaine‐induced dopamine increase and immediate early gene expression in rat brain

  2001cited by this paper
• Localization of natriuretic peptide‐activated guanylate cyclase mRNAs in the rat brain

  1996cited by this paper
• Distribution of natriuretic peptide precursor mRNAs in the rat brain

  1995cited by this paper
• Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

  1992cited by this paper
• C-type natriuretic peptide (CNP) in rats and humans.

  1991cited by this paper
• The LMS method for constructing normalized growth standards.

  1990cited by this paper
• Enkephalinergic Markers in Substantia Nigra and Caudate Nucleus from Parkinsonian Subjects

  1984cited by this paper

• Restless Leg Syndrome and Association with Serum NT Pro-CNP.

  2026cites this paper
• Potential diagnostic markers and therapeutic targets for major depressive disorder based on bioinformatics analysis and molecular docking studies

  2025cites this paper
• Screening of the Key Genes and Signaling Pathways for Schizophrenia Using Bioinformatics and Next Generation Sequencing Data Analysis

  2023cites this paper
• N-Terminal Pro-C-Type Natriuretic Peptide: The Novel Marker in Selected Disease Units.

  2021cites this paper
• Applications in medicine: mental health

  2021cites this paper
• Natriuretic peptides are neuroprotective on in vitro models of PD and promote dopaminergic differentiation of hiPSCs-derived neurons via the Wnt/β-catenin signaling

  2021cites this paper
• Circulating products of C-type Natriuretic Peptide and links with organ function in health and disease.

  2020cites this paper
• Environmental Enrichment Elicits a Transient Rise of Bioactive C-Type Natriuretic Peptide in Young but Not Aged Rats

  2018cites this paper